Do epigenetic marks govern bone mass and homeostasis?

Current Genomics

Volumn 13, Issue 3, 2012, Pages 252-263

  Delgado Calle, Jesús ^a   Garmilla, Pablo ^a   Riancho, José A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

DNA methylation; Gene expression; Histones; miRNA; Osteoblasts; Osteoclasts; Osteoporosis

Indexed keywords

BONE DEVELOPMENT; BONE GROWTH; BONE MASS; BONE REMODELING; CELL DIFFERENTIATION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; REVIEW;

EID: 84860537308     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920212800543129     Document Type: Review

References (127)

1. Melton, L.J. How many women have osteoporosis now? J. Bone Miner. Res., 1995, 10, 175-177.
2. Ralston, S.H. Genetic control of susceptibility to osteoporosis. J. Clin. Endocrinol. Metab., 2002, 87, 2460-2466.
3. Peacock, M.; Turner, C.H.; Econs, M.J.; Foroud, T. Genetics of osteoporosis. Endocr. Rev., 2002, 23, 303-326.
4. Nguyen, T.V.; Howard, G.M.; Kelly, P.J.; Eisman, J.A. Bone mass, lean mass, and fat mass: same genes or same environments? Am. J. Epidemiol., 1998, 147, 3-16.
5. Cummings, S.R.; Nevitt, M.C.; Browner, W.S.; Stone, K.; Fox, K.M.; Ensrud, K.E.; Cauley, J.; Black, D.; Vogt, T.M. Risk factors for hip fracture in white women. N. Engl. J. Med., 1995, 332, 767-773.
6. Kanis, J.A.; Johansson, H.; Oden, A.; Johnell, O.; De Laet, C.; Eisman, J.A.; McCloskey, E.V.; Mellstrom, D.; Melton, L.J., III; Pols, H.A.; Reeve, J.; Silman, A.J.; Tenenhouse, A. A family history of fracture and fracture risk: a meta-analysis. Bone, 2004, 35, 1029-1037.
7. Hernandez, C.J.; Beaupr, G.S.; Carter, D.R. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos. Int., 2003, 14, 843-847.
8. Brown, L.B.; Streeten, E.A.; Shapiro, J.R.; McBride, D.; Shuldiner, A.R.; Peyser, P.A.; Mitchell, B.D. Genetic and environmental influences on bone mineral density in pre-and post-menopausal women. Osteoporos. Int., 2005, 16, 1849-1856.
9. Michaelsson, K.; Melhus, H.; Ferm, H.; Ahlbom, A.; Pedersen, N.L. Genetic liability to fractures in the elderly. Arch. Intern. Med., 2005, 165, 1825-1830.
10. Ralston, S.H.; de Crombrugghe, B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev., 2006, 20, 2492-2506.
11. Velasco, J.; Zarrabeitia, M.T.; Prieto, J.R.; Perez-Castrillon, J.L.; Perez-Aguilar, M.D.; Perez-Nunez, M.I.; Sanudo, C.; Hernandez-Elena, J.; Calvo, I.; Ortiz, F.; Gonzalez-Macias, J.; Riancho, J.A. Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study. Osteoporos. Int., 2010, 21, 109-118.
12. Esteller, M. Cancer Epigenetics for the 21st Century: What's Next? Genes Cancer, 2011, 2, 604-606.
13. Irizarry, R.A.; Ladd-Acosta, C.; Wen, B.; Wu, Z.; Montano, C.; Onyango, P.; Cui, H.; Gabo, K.; Rongione, M.; Webster, M.; Ji, H.; Potash, J.B.; Sabunciyan, S.; Feinberg, A.P. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet., 2009, 41, 178-186.
14. Munzel, M.; Globisch, D.; Carell, T. 5-Hydroxymethylcytosine, the sixth base of the genome. Angew. Chem. Int. Ed Engl., 2011, 50, 6460-6468.
15. Hermann, A.; Gowher, H.; Jeltsch, A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol. Life Sci., 2004, 61, 2571-2587.
16. Turek-Plewa, J.; Jagodzinski, P.P. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol. Biol. Lett., 2005, 10, 631-647.
17. Kouzarides, T. Chromatin modifications and their function. Cell, 2007, 128, 693-705.
18. Shilatifard, A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem., 2006, 75, 243-269.
19. Santos-Rosa, H.; Caldas, C. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer, 2005, 41, 2381-2402.
20. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75, 843-854.
21. Bentwich, I.; Avniel, A.; Karov, Y.; Aharonov, R.; Gilad, S.; Barad, O.; Barzilai, A.; Einat, P.; Einav, U.; Meiri, E.; Sharon, E.; Spector, Y.; Bentwich, Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet., 2005, 37, 766-770.
22. Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19, 92-105.
23. Kim, V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol., 2005, 6, 376-385.
24. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116, 281-297.
25. Fuks, F.; Hurd, P.J.; Wolf, D.; Nan, X.; Bird, A.P.; Kouzarides, T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem., 2003, 278, 4035-4040.
26. Gal-Yam, E.N.; Saito, Y.; Egger, G.; Jones, P.A. Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med., 2008, 59, 267-280.
27. Szulwach, K.E.; Li, X.; Smrt, R.D.; Li, Y.; Luo, Y.; Lin, L.; Santistevan, N.J.; Li, W.; Zhao, X.; Jin, P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol., 2010, 189, 127-141.
28. Sato, F.; Tsuchiya, S.; Meltzer, S.J.; Shimizu, K. MicroRNAs and epigenetics. FEBS J., 2011, 278, 1598-1609.
29. Liang, R.; Bates, D.J.; Wang, E. Epigenetic Control of MicroRNA Expression and Aging. Curr. Genomics, 2009, 10, 184-193.
30. Teti, A. Bone Development: Overview of Bone Cells and Signaling. Curr. Osteoporos. Rep., 2011, 9, 264-73.
31. Nakashima, T.; Hayashi, M.; Fukunaga, T.; Kurata, K.; Oh-Hora, M.; Feng, J.Q.; Bonewald, L.F.; Kodama, T.; Wutz, A.; Wagner, E.F.; Penninger, J.M.; Takayanagi, H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med., 2011, 17, 1231-1234.
32. Xiong, J.; Onal, M.; Jilka, R.L.; Weinstein, R.S.; Manolagas, S.C.; O'Brien, C.A. Matrix-embedded cells control osteoclast formation. Nat. Med., 2011, 17, 1235-1241
33. Logar, D.B.; Komadina, R.; Prezelj, J.; Ostanek, B.; Trost, Z.; Marc, J. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J. Bone Miner. Metab., 2007, 25, 219-225.
34. D'Amelio, P.; Roato, I.; D'Amico, L.; Veneziano, L.; Suman, E.; Sassi, F.; Bisignano, G.; Ferracini, R.; Gargiulo, G.; Castoldi, F.; Pescarmona, G.P.; Isaia, G.C. Bone and bone marrow proosteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos. Int., 2011, 22, 2869-2877.
35. Rochefort, G.Y.; Pallu, S.; Benhamou, C.L. Osteocyte: the unrecognized side of bone tissue. Osteoporos. Int., 2010, 21, 1457-1469.
36. Jackson, L.; Jones, D.R.; Scotting, P.; Sottile, V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J. Postgrad. Med., 2007, 53, 121-127.
37. Noble, B.S. The osteocyte lineage. Arch. Biochem. Biophys., 2008, 473, 106-111.
38. Kang, M.I.; Kim, H.S.; Jung, Y.C.; Kim, Y.H.; Hong, S.J.; Kim, M.K.; Baek, K.H.; Kim, C.C.; Rhyu, M.G. Transitional CpG methylation between promoters and retroelements of tissue-specific genes during human mesenchymal cell differentiation. J. Cell Biochem., 2007, 102, 224-239.
39. Bonewald, L.F. The amazing osteocyte. J. Bone Miner. Res., 2011, 26, 229-238.
40. Hantusch, B.; Kalt, R.; Krieger, S.; Puri, C.; Kerjaschki, D. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC. Mol. Biol., 2007, 8, 20.
41. Miao, D.; Scutt, A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J. Histochem. Cytochem., 2002, 50, 333-340.
42. Delgado-Calle, J.; Sanudo, C.; Sanchez-Verde, L.; Garcia-Renedo, R.J.; Arozamena, J.; Riancho, J.A. Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage. Bone, 2011, 49, 830-838.
43. Semenov, M.; Tamai, K.; He, X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem., 2005, 280, 26770-26775.
44. Delgado-Calle, J.; Sanudo, C.; Bolado, A.; Fernández, A.F.; Arozamena, J.; Pascual-Carra, M.A.; Rodriguez-Rey, J.C.; Fraga, M. F.; Bonewald, L.F.; Riancho, J.A. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J. Bone Miner. Res., 2011. In press.
45. Cohen-Kfir, E.; Artsi, H.; Levin, A.; Abramowitz, E.; Bajayo, A.; Gurt, I.; Zhong, L.; D'Urso, A.; Toiber, D.; Mostoslavsky, R.; Dresner-Pollak, R. Sirt1 Is a Regulator of Bone Mass and a Repressor of Sost Encoding for Sclerostin: A Bone Formation Inhibitor. Endocrinology, 2011, 152, 4514-4524.
46. Locklin, R.M.; Oreffo, R.O.; Triffitt, J.T. Modulation of osteogenic differentiation in human skeletal cells in vitro by 5-azacytidine. Cell Biol. Int., 1998, 22, 207-215.
47. Arnsdorf, E.J.; Tummala, P.; Castillo, A.B.; Zhang, F.; Jacobs, C.R. The epigenetic mechanism of mechanically induced osteogenic differentiation. J. Biomech., 2010, 43, 2881-2886.
48. Villagra, A.; Gutierrez, J.; Paredes, R.; Sierra, J.; Puchi, M.; Imschenetzky, M.; Wijnen, A.A.; Lian, J.; Stein, G.; Stein, J.; Montecino, M. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J. Cell Biochem., 2002, 85, 112-122.
49. Dansranjavin, T.; Krehl, S.; Mueller, T.; Mueller, L.P.; Schmoll, H.J.; Dammann, R.H. The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation. Cell Cycle, 2009, 8, 916-924.
50. Loeser, R.F.; Im, H.J.; Richardson, B.; Lu, Q.; Chubinskaya, S. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage, 2008, 17, 513-517.
51. Lee, J.Y.; Lee, Y.M.; Kim, M.J.; Choi, J.Y.; Park, E.K.; Kim, S.Y.; Lee, S.P.; Yang, J.S.; Kim, D.S. Methylation of the mouse DIx5 and Osx gene promoters regulates cell type-specific gene expression. Mol. Cell, 2006, 22, 182-188.
52. Penolazzi, L.; Lambertini, E.; Giordano, S.; Sollazzo, V.; Traina, G.; del Senno, L.; Piva, R. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells. J. Steroid Biochem. Mol. Biol., 2004, 91, 1-9.
53. Demura, M.; Bulun, S.E. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity. Mol. Cell Endocrinol., 2008, 283, 127-132.
54. Gordon, J.A.; Hassan, M.Q.; Koss, M.; Montecino, M.; Selleri, L.; van Wijnen, A.J.; Stein, J.L.; Stein, G.S.; Lian, J.B. Epigenetic regulation of early osteogenesis and mineralized tissue formation by a HOXA10-PBX1-associated complex. Cells Tissues Organs, 2011, 194, 146-150.
55. Shen, J.; Hovhannisyan, H.; Lian, J.B.; Montecino, M.A.; Stein, G.S.; Stein, J.L.; van Wijnen, A.J. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol. Endocrinol., 2003, 17, 743-756.
56. Hassan, M.Q.; Saini, S.; Gordon, J.A.; van Wijnen, A.J.; Montecino, M.; Stein, J.L.; Stein, G.S.; Lian, J.B. Molecular switches involving homeodomain proteins, HOXA10 and RUNX2 regulate osteoblastogenesis. Cells Tissues Organs, 2009, 189, 122-125.
57. Fan, Z.; Yamaza, T.; Lee, J.S.; Yu, J.; Wang, S.; Fan, G.; Shi, S.; Wang, C.Y. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat. Cell Biol., 2009, 11, 1002-1009.
58. Jensen, E.D.; Gopalakrishnan, R.; Westendorf, J.J. Regulation of gene expression in osteoblasts. Biofactors, 2010, 36, 25-32.
59. Gao, J.; Yang, T.; Han, J.; Yan, K.; Qiu, X.; Zhou, Y.; Fan, Q.; Ma, B. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J. Cell Biochem., 2011, 112, 1844-1856.
60. Komori, T. Regulation of osteoblast differentiation by Runx2. Adv. Exp. Med. Biol., 2010, 658, 43-49.
61. Sevetson, B.; Taylor, S.; Pan, Y. Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST). J. Biol. Chem., 2004, 279, 13849-13858.
62. Huang, J.; Zhao, L.; Xing, L.; Chen, D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cell, 2010, 28, 357-364.
63. Schaap-Oziemlak, A.M.; Raymakers, R.A.; Bergevoet, S.M.; Gilissen, C.; Jansen, B.J.; Adema, G.J.; Kogler, G.; le Sage, C.; Agami, R.; van der Reijden, B.A.; Jansen, J.H. MicroRNA hsamiR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev., 2010, 19, 877-885.
64. Li, Z.; Hassan, M.Q.; Volinia, S.; van Wijnen, A.J.; Stein, J.L.; Croce, C.M.; Lian, J.B.; Stein, G.S. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 13906-13911.
65. Hassan, M.Q.; Gordon, J.A.; Beloti, M.M.; Croce, C.M.; van Wijnen, A.J.; Stein, J.L.; Stein, G.S.; Lian, J.B. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 19879-19884.
66. Javed, A.; Bae, J.S.; Afzal, F.; Gutierrez, S.; Pratap, J.; Zaidi, S.K.; Lou, Y.; van Wijnen, A.J.; Stein, J.L.; Stein, G.S.; Lian, J.B. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J. Biol. Chem., 2008, 283, 8412-8422.
67. Luzi, E.; Marini, F.; Sala, S.C.; Tognarini, I.; Galli, G.; Brandi, M.L. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J. Bone Miner. Res., 2008, 23, 287-295.
68. Itoh, T.; Nozawa, Y.; Akao, Y. MicroRNA-141 and-200a are involved in bone morphogenetic protein-2-induced mouse preosteoblast differentiation by targeting distal-less homeobox 5. J. Biol. Chem., 2009, 284, 19272-19279.
69. Inose, H.; Ochi, H.; Kimura, A.; Fujita, K.; Xu, R.; Sato, S.; Iwasaki, M.; Sunamura, S.; Takeuchi, Y.; Fukumoto, S.; Saito, K.; Nakamura, T.; Siomi, H.; Ito, H.; Arai, Y.; Shinomiya, K.; Takeda, S. A microRNA regulatory mechanism of osteoblast differentiation. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 20794-20799.
70. Kapinas, K.; Kessler, C.; Ricks, T.; Gronowicz, G.; Delany, A.M. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem., 2010, 285, 25221-25231.
71. Mizuno, Y.; Yagi, K.; Tokuzawa, Y.; Kanesaki-Yatsuka, Y.; Suda, T.; Katagiri, T.; Fukuda, T.; Maruyama, M.; Okuda, A.; Amemiya, T.; Kondoh, Y.; Tashiro, H.; Okazaki, Y. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem. Biophys. Res. Commun., 2008, 368, 267-272.
72. Li, Z.; Hassan, M.Q.; Jafferji, M.; Aqeilan, R.I.; Garzon, R.; Croce, C.M.; van Wijnen, A.J.; Stein, J.L.; Stein, G.S.; Lian, J.B. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem., 2009, 284, 15676-15684.
73. Jafferji, M. Regulation of osteoblast differentiation by microRNAs. PhD Thesis, Worcester Polytechnic Institute: Worcester, MA, 2009.
74. Kim, Y.J.; Bae, S.W.; Yu, S.S.; Bae, Y.C.; Jung, J.S. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J. Bone Miner. Res., 2009, 24, 816-825.
75. Zhang, J.; Tu, Q.; Bonewald, L.F.; He, X.; Stein, G.; Lian, J.; Chen, J. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J. Bone Miner. Res., 2011, 26, 1953-1963.
76. Sims, N.A.; Gooi, J.H. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin. Cell Dev. Biol., 2008, 19, 444-451.
77. Raggatt, L.J.; Partridge, N.C. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem., 2010, 285, 25103-25108.
78. Matsuo, K.; Irie, N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys., 2008, 473, 201-209.
79. Kitazawa, R.; Kitazawa, S. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell-and tissue-specific RANKL expression and osteoclastogenesis. Mol. Endocrinol., 2007, 21, 148-158.
80. Delgado-Calle, J.; Sañudo C; Fernández AF; García-Renedo R; Fraga MF; Riancho JA Epigenetics mechanisms modulate the expression of genes controlling osteoclast differentiation. J Bone Miner. Res., 2011, 26, S449.
81. Kearns, A.E.; Khosla, S.; Kostenuik, P.J. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev., 2008, 29, 155-192.
82. Wright, H.L.; McCarthy, H.S.; Middleton, J.; Marshall, M.J. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr. Rev. Musculoskelet. Med., 2009, 2, 56-64.
83. Zhao, Q.; Wang, X.; Liu, Y.; He, A.; Jia, R. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol., 2010, 42, 576-579.
84. Yasui, T.; Hirose, J.; Tsutsumi, S.; Nakamura, K.; Aburatani, H.; Tanaka, S. Epigenetic regulation of osteoclast differentiation: Possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J. Bone Miner. Res., 2011. 26, 2665-2671.
85. Nakasa, T.; Shibuya, H.; Nagata, Y.; Niimoto, T.; Ochi, M. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum., 2011, 63, 1582-1590.
86. Boyce, B.F.; Xing, L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys., 2008, 473, 139-146.
87. Aoki, S.; Honma, M.; Kariya, Y.; Nakamichi, Y.; Ninomiya, T.; Takahashi, N.; Udagawa, N.; Suzuki, H. Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. J. Bone Miner. Res., 2010, 25, 1907-1921.
88. Kong, Y.Y.; Yoshida, H.; Sarosi, I.; Tan, H.L.; Timms, E.; Capparelli, C.; Morony, S.; Oliveira-dos-Santos, A.J.; Van, G.; Itie, A.; Khoo, W.; Wakeham, A.; Dunstan, C.R.; Lacey, D.L.; Mak, T.W.; Boyle, W.J.; Penninger, J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 1999, 397, 315-323.
89. Bucay, N.; Sarosi, I.; Dunstan, C.R.; Morony, S.; Tarpley, J.; Capparelli, C.; Scully, S.; Tan, H.L.; Xu, W.; Lacey, D.L.; Boyle, W.J.; Simonet, W.S. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev., 1998, 12, 1260-1268.
90. Li, J.; Sarosi, I.; Yan, X.Q.; Morony, S.; Capparelli, C.; Tan, H.L.; McCabe, S.; Elliott, R.; Scully, S.; Van, G.; Kaufman, S.; Juan, S.C.; Sun, Y.; Tarpley, J.; Martin, L.; Christensen, K.; McCabe, J.; Kostenuik, P.; Hsu, H.; Fletcher, F.; Dunstan, C.R.; Lacey, D.L.; Boyle, W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 1566-1571.
91. Lu, T.Y.; Kao, C.F.; Lin, C.T.; Huang, D.Y.; Chiu, C.Y.; Huang, Y.S.; Wu, H.C. DNA methylation and histone modification regulate silencing of OPG during tumor progression. J. Cell Biochem., 2009, 108, 315-325.
92. Cantley, M.D.; Fairlie, D.P.; Bartold, P.M.; Rainsford, K.D.; Le, G.T.; Lucke, A.J.; Holding, C.A.; Haynes, D.R. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro. J. Cell Physiol., 2011, 226, 3233-3241.
93. Mizoguchi, F.; Izu, Y.; Hayata, T.; Hemmi, H.; Nakashima, K.; Nakamura, T.; Kato, S.; Miyasaka, N.; Ezura, Y.; Noda, M. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J. Cell Biochem., 2010, 109, 866-875.
94. Sugatani, T.; Hruska, K.A. MicroRNA-223 is a key factor in osteoclast differentiation. J. Cell Biochem., 2007, 101, 996-999.
95. Mann, M.; Barad, O.; Agami, R.; Geiger, B.; Hornstein, E. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 15804-15809.
96. Sugatani, T.; Vacher, J.; Hruska, K.A. A microRNA expression signature of osteoclastogenesis. Blood, 2011, 117, 3648-3657.
97. Yu, F.; Cui, Y.; Zhou, X.; Zhang, X.; Han, J. Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells. Biosci. Trends, 2011, 5, 46-51.
98. Fraga, M.F.; Esteller, M. Epigenetics and aging: the targets and the marks. Trends Genet., 2007, 23, 413-418.
99. Holroyd, C.; Harvey, N.; Dennison, E.; Cooper, C. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos. Int., 2011. In press.
100. Harvey, N.; Mahon, P.; Robinson, S.; Nisbet, C.; Javaid, M.; Crozier, S.; Inskip, H.; Godfrey, K.; Arden, N.; Dennison, E.; Cooper, C. Different Indices of Fetal Growth Predict Bone Size and Volumetric Density at 4 Years Old. J Bone Miner. Res., 2009.
101. Mahon, P.; Harvey, N.; Crozier, S.; Inskip, H.; Robinson, S.; Arden, N.; Swaminathan, R.; Cooper, C.; Godfrey, K. Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner. Res., 2010, 25, 14-19.
102. Baird, J.; Kurshid, M.A.; Kim, M.; Harvey, N.; Dennison, E.; Cooper, C. Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. Osteoporos. Int., 2011, 22, 1323-1334.
103. Lanham, S.A.; Roberts, C.; Perry, M.J.; Cooper, C.; Oreffo, R.O. Intrauterine programming of bone. Part 2: alteration of skeletal structure. Osteoporos. Int., 2008, 19, 157-167.
104. Oreffo, R.O.; Lashbrooke, B.; Roach, H.I.; Clarke, N.M.; Cooper, C. Maternal protein deficiency affects mesenchymal stem cell activity in the developing offspring. Bone, 2003, 33, 100-107.
105. Lillycrop, K.A.; Phillips, E.S.; Torrens, C.; Hanson, M.A.; Jackson, A.A.; Burdge, G.C. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br. J. Nutr., 2008, 100, 278-282.
106. Lillycrop, K.A.; Slater-Jefferies, J.L.; Hanson, M.A.; Godfrey, K.M.; Jackson, A.A.; Burdge, G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br. J. Nutr., 2007, 97, 1064-1073.
107. Lillycrop, K.A.; Phillips, E.S.; Jackson, A.A.; Hanson, M.A.; Burdge, G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr., 2005, 135, 1382-1386.
108. Heijmans, B.T.; Tobi, E.W.; Stein, A.D.; Putter, H.; Blauw, G.J.; Susser, E.S.; Slagboom, P.E.; Lumey, L.H. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci U. S. A., 2008, 105, 17046-17049.
109. Heijmans, B.T.; Tobi, E.W.; Lumey, L.H.; Slagboom, P.E. The epigenome: archive of the prenatal environment. Epigenetics, 2009, 4, 526-531.
110. Lei, S.F.; Papasian, C.J.; Deng, H.W. Polymorphisms in predicted miRNA binding sites and osteoporosis. J. Bone Miner. Res., 2011, 26, 72-78.
111. Li, H.; Xie, H.; Liu, W.; Hu, R.; Huang, B.; Tan, Y.F.; Xu, K.; Sheng, Z.F.; Zhou, H.D.; Wu, X.P.; Luo, X.H. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest., 2009, 119, 3666-3677.
112. Eskildsen, T.; Taipaleenmaki, H.; Stenvang, J.; Abdallah, B.M.; Ditzel, N.; Nossent, A.Y.; Bak, M.; Kauppinen, S.; Kassem, M. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 6139-6144.
113. Smith, P.N.; Freeman, C.; Yu, D.; Chen, M.; Gatenby, P.A.; Parish, C.R.; Li, R.W. Heparanase in primary human osteoblasts. J. Orthop. Res., 2010, 28, 1315-1322.
114. Shimizu, E.; Selvamurugan, N.; Westendorf, J.J.; Partridge, N.C. Parathyroid hormone regulates histone deacetylases in osteoblasts. Ann. N. Y. Acad. Sci., 2007, 1116, 349-353.
115. Tseng, P.C.; Hou, S.M.; Chen, R.J.; Peng, H.W.; Hsieh, C.F.; Kuo, M.L.; Yen, M.L. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J. Bone Miner. Res., 2011, 26, 2552-2563.
116. Zhou, Q.; Zhao, Z.N.; Cheng, J.T.; Zhang, B.; Xu, J.; Huang, F.; Zhao, R.N.; Chen, Y.J. Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs. Biochem. Biophys. Res. Commun., 2011, 404, 127-132.
117. Riancho JA Genetics of osteoporosis: half-full or half-empty?. Crit. Rev. Bone Miner. Metab., 2010, 49-50.
118. Bell, J.T.; Pai, A.A.; Pickrell, J.K.; Gaffney, D.J.; Pique-Regi, R.; Degner, J.F.; Gilad, Y.; Pritchard, J.K. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol., 2011, 12, R10.
119. Scholer, N.; Langer, C.; Dohner, H.; Buske, C.; Kuchenbauer, F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp. Hematol., 2010, 38, 1126-1130.
120. Soifer, H.S.; Rossi, J.J.; Saetrom, P. MicroRNAs in disease and potential therapeutic applications. Mol. Ther., 2007, 15, 2070-2079.
121. La Thangue, N.B. Histone deacetylase inhibitors and cancer therapy. J. Chemother., 2004, 16 Suppl 4, 64-67.
122. Santos, F.P.; Kantarjian, H.; Garcia-Manero, G.; Issa, J.P.; Ravandi, F. Decitabine in the treatment of myelodysplastic syndromes. Expert. Rev. Anticancer Ther., 2010, 10, 9-22.
123. Fabbri, E.; Brognara, E.; Borgatti, M.; Lampronti, I.; Finotti, A.; Bianchi, N.; Sforza, S.; Tedeschi, T.; Manicardi, A.; Marchelli, R.; Corradini, R.; Gambari, R. miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs. Epigenomics, 2011, 3, 733-745.
124. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438, 685-689.
125. Itoh, T.; Takeda, S.; Akao, Y. MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1. J. Biol. Chem., 2010, 285, 27745-27752.
126. Mizuno, Y.; Tokuzawa, Y.; Ninomiya, Y.; Yagi, K.; Yatsuka-Kanesaki, Y.; Suda, T.; Fukuda, T.; Katagiri, T.; Kondoh, Y.; Amemiya, T.; Tashiro, H.; Okazaki, Y. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett., 2009, 583, 2263-2268.
127. Zhang, Y.; Xie, R.L.; Croce, C.M.; Stein, J.L.; Lian, J.B.; van Wijnen, A.J.; Stein, G.S. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 9863-9868.